MedTrace Logo

Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer

NCT07046936 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-05-18

No results posted yet for this study

Summary

The purpose of this research study is to see if patients with endometrial and ovarian cancer are willing to complete physical and cognitive assessments before treatment and again after treatment has ended.

Conditions

  • Gynecologycal Cancer

Interventions

DIAGNOSTIC_TEST

muscle sample

For participants undergoing standard of care interval cytoreductive surgery via laparotomy, a skeletal muscle biopsy from the rectus abdominis muscle (1 cm x 1 cm x 1 cm, \~300 mg) will be collected. For participants who undergo standard of care interval cytoreductive surgery with a laparoscopic approach, a skeletal muscle biopsy will be taken from either the rectus abdominis (1 cm x 1 cm x 1 cm, \~300 mg) or the psoas (1 cm x 0.5 cm x 0.5 cm, \~200 mg) muscle.

OTHER

blood draw

A total of approximately 60mL or 4 tablespoons of blood will be collected throughout the study

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Bumsoo Ahn, PhD · Wake Forest University Health Sciences

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-10
Primary Completion
2027-04-30
Completion
2027-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07046936 on ClinicalTrials.gov